TLSI Reports $8.9M Q1 Revenue, 86.2% Gross Margin, Raises $46M in Equity, Revises 2026 Guidance to $54-57M
TriSalus Life Sciences, Inc. Common Stock · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $3.67
-41% in 1d after detection
Post-detection moves
1h
—
1d
-41%
3d
-41%
7d
-24%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS